(Q33946141)

30 July 2017

1 reference

title

Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Growth, development, and therapeutic considerations (English)

1 reference

congenital adrenal hyperplasia

30 July 2017

0 references

1 reference

1

Migeon CJ

1 reference

30 July 2017

2

Wisniewski AB

1 reference

30 July 2017

publication date

1 March 2001

1 reference

Endocrinology and Metabolism Clinics of North America

30 July 2017

published in

1 reference

30 July 2017

volume

30

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

193-206

1 reference

Growth in Congenital Adrenal Hyperplasia

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Experience with long-term therapy in congenital adrenal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Obesity in 21-hydroxylase deficient patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

The Effect of Therapy on Mature Height in Congenital Adrenal Hyperplasia*

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effects on height, sexual maturation, and fertility

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Growth hormone prevents steroid-induced growth depression in health and uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Integrated concentration of plasma cortisol in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Treatment of familial male precocious puberty with spironolactone and testolactone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Bone loss in response to long-term glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Micropenis: Does Early Treatment with Testosterone Do More Harm Than Good?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Bone density in young patients with congenital adrenal hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Linear growth rate, bone maturation and growth hormone secretion in prepubertal children with congenital adrenal hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Adiposity rebound in children: a simple indicator for predicting obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

The Effect of Prepubertal Androgen Exposure on Adult Penile Length

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Adult Height and Fertility in Men with Congenital Virilizing Adrenal Hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

On the regulation of sex-hormone-binding globulin--a challenge of an old dogma and outlines of an alternative mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Glucocorticoids: potent inhibitors and stimulators of growth hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Adult height in women with early-treated congenital adrenal hyperplasia (21-hydroxylase type): relation to body mass index in earlier childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

Intercomparison of four methods for measuring cortisol production.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

17alpha-Hydroxyprogesterone--a salt-losing steroid: relation to congenital adrenal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970026-4

7 January 2021

10.1016/S0889-8529(08)70026-4

Identifiers

DOI

1 reference

30 July 2017

1 reference